HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SUPPDM SASDATA 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 Supplemental Qualifiers for DM HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001000000000000000000000 STUDYID Study Identifier RDOMAIN Related Domain Abbreviation USUBJID Unique Subject Identifier IDVAR Identifying Variable IDVARVALIdentifying Variable Value !QNAM Qualifier Variable Name "#QLABEL Qualifier Variable Label *)QVAL Data Value M QORIG Origin v QEVAL Evaluator } HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001DMC4591001 1005 10051317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051410 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051410 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051412 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051412 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051413 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051413 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051415 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051415 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051417 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051417 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051418 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051418 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051419 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051419 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051420 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051420 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051421 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051421 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051422 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051422 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051424 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051424 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051425 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051425 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051427 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051427 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051429 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051429 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051430 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051430 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051431 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051431 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051436 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051436 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051437 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051437 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051438 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051438 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051439 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051439 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051440 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051440 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051441 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051441 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051444 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051444 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051445 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051445 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051447 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051447 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051448 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051448 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051449 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051449 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051450 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051450 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1005 10051450 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051451 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1005 10051451 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061183 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061183 RACE1 Race1 AMERICAN INDIAN OR ALASKA NATIVE CRF C4591001DMC4591001 1006 10061183 RACE2 Race2 WHITE CRF C4591001DMC4591001 1006 10061183 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061184 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061184 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061188 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061188 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061189 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061189 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061190 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061190 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061191 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061191 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061196 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061196 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061200 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061200 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061201 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061201 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061203 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061203 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061206 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061206 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061207 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061207 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061209 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061209 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061212 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061212 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061213 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061213 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061214 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061214 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061219 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061219 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061220 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061220 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061221 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061221 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061223 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061223 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061224 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061224 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061226 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061226 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061227 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061227 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061228 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061228 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061230 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061230 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1006 10061230 RACE2 Race2 WHITE CRF C4591001DMC4591001 1006 10061230 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061231 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061231 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061232 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061232 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061234 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061234 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061237 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061237 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061260 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061266 RACE1 Race1 NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERCRF C4591001DMC4591001 1006 10061266 RACE2 Race2 WHITE CRF C4591001DMC4591001 1006 10061266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061267 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1006 10061267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061285 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1006 10061300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071409 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071409 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071415 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071415 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071417 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071417 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071429 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071429 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071467 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071467 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071469 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071469 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071471 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071471 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071472 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071472 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071475 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071475 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071476 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071476 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071478 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071478 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071480 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071480 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071481 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071481 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071482 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071482 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071483 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071483 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071484 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071484 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071485 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071485 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071488 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071488 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071490 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071490 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071492 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071492 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071494 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071494 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071495 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071495 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071496 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071496 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071497 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071497 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071499 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071499 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071500 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071500 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071504 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071504 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071505 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071505 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071506 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071506 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071507 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071507 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071508 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071508 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071509 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071509 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071511 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071511 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071512 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071512 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071514 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071514 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071515 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071515 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071516 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071516 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071517 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071517 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071518 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071518 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071519 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071519 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071520 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071520 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071521 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071521 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071522 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071522 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071523 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071523 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071524 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071524 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071525 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071525 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071526 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071526 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071527 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071527 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071528 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071528 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071529 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071529 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1007 10071529 RACE2 Race2 WHITE CRF C4591001DMC4591001 1007 10071529 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071530 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071530 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071531 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071531 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071533 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071533 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071535 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071535 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071536 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071536 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071537 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071537 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071539 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071539 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071540 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071540 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071541 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071541 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071542 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071542 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071543 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071543 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071544 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071544 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071546 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071546 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071547 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071547 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071550 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071550 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071551 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071551 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071552 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071552 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071554 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071554 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071555 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071555 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071557 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071557 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071558 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071558 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071559 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071559 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071560 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071560 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071561 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071561 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071562 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071562 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071563 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071563 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071564 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071564 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071565 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071565 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071566 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071566 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071567 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071567 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071568 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071568 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071569 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071569 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071570 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071570 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071571 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071571 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071572 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071572 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071573 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071573 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071574 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071574 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071575 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071575 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071576 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071576 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071577 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071577 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1007 10071577 RACE2 Race2 WHITE CRF C4591001DMC4591001 1007 10071577 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071578 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071578 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1007 10071578 RACE2 Race2 WHITE CRF C4591001DMC4591001 1007 10071578 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071579 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071579 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071580 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071580 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071581 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071581 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071582 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071582 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071583 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071583 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071584 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071584 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071585 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071585 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071586 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071586 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071587 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071587 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071588 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071588 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071589 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071589 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071590 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071590 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071591 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071591 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071592 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071592 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071593 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071593 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071594 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071594 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071595 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071595 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071596 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071596 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071597 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071597 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071599 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071599 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071600 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071600 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071601 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071601 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1007 10071601 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071602 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071602 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071603 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071603 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071604 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071604 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071605 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071605 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071606 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071606 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071607 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071607 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071608 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071608 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071609 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071609 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071610 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071610 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071612 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071612 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071613 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071613 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071614 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071614 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071615 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071615 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071616 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071616 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071617 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071617 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071618 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071618 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071619 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071619 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071620 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071620 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071621 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071621 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071622 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071622 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071623 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071623 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071624 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071624 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071625 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071625 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071626 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071626 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071627 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071627 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071628 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071628 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071629 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071629 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1007 10071629 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071630 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071630 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1007 10071630 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071631 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071631 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071632 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071632 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071633 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071633 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071634 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071634 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071635 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071635 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071636 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071636 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071638 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071638 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071639 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071639 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071640 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071640 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071641 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071641 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071642 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071642 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071643 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071643 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071644 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071644 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071645 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071645 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071646 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071646 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071647 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071647 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071648 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071648 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1007 10071648 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071649 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071649 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071650 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071650 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071651 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071651 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071652 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071652 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071653 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071653 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071654 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071654 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071655 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071655 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071656 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071656 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071658 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071658 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071659 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071659 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071660 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071660 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071661 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071661 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071662 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1007 10071662 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081751 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081751 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081752 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081752 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081753 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081753 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081754 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081754 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081755 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081755 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081756 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081756 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081757 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081757 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081758 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081758 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081760 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081760 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081761 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081761 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081763 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081763 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081764 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081764 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081767 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081767 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081768 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081768 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081769 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081769 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081770 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081770 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081771 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081771 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081773 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081773 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081774 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081774 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081775 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081775 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081777 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081777 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081780 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081780 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081781 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081781 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081785 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081785 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081788 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081788 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081789 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081789 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081790 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081790 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081791 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081791 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081792 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081792 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081793 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081793 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081794 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081794 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081795 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081795 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081796 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081796 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081797 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081797 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081798 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081798 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081799 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081799 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081800 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081800 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081801 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081801 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081802 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081802 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081803 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081803 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081804 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081804 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081805 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081805 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081805 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081806 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081806 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081807 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081807 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081808 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081808 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081808 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081809 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081809 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081810 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081810 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081811 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081811 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081812 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081812 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081813 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081813 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081814 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081814 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081815 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081815 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081816 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081816 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081817 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081817 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081817 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081818 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081818 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081819 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081819 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081820 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081820 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081821 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081821 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081822 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081822 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081823 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081823 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081824 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081824 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081825 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081825 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081826 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081826 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081827 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081827 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081828 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081828 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081829 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081829 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081830 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081830 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081831 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081831 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081832 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081832 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081833 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081833 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081834 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081834 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081835 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081835 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081836 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081836 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081837 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081837 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081838 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081838 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081839 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081839 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081840 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081840 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081841 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081841 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081842 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081842 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081843 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081843 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081844 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081844 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081845 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081845 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081846 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081846 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081847 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081847 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081848 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081848 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081849 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081849 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081850 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081850 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081851 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081851 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081852 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081852 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081853 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081853 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081854 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081854 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081854 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081855 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081855 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081855 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081856 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081856 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081857 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081857 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081858 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081858 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081859 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081859 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081860 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081860 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081861 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081861 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081862 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081862 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081863 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081863 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081863 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081864 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081864 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081864 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081865 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081865 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081866 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081866 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081867 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081867 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081868 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081868 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081869 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081869 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081870 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081870 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081871 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081871 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081872 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081872 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081873 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081873 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081874 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081874 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081875 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081875 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081876 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081876 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081877 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081877 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081878 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081878 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081879 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081879 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081880 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081880 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081881 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081881 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081882 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081882 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081883 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081883 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081884 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081884 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081885 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081885 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081886 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081886 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081887 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081887 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081888 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081888 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081889 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081889 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081890 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081890 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081891 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081891 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081892 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081892 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081893 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081893 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081894 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081894 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081895 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081895 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081896 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081896 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081897 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081897 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081898 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081898 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081899 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081899 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081900 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081900 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081901 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081901 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081902 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081902 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081903 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081903 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081904 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081904 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081905 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081905 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081906 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081906 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081907 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081907 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081908 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081908 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081909 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081909 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081910 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081910 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081911 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081911 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081912 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081912 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081913 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081913 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081914 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081914 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081915 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081915 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081916 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081916 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081917 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081917 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081918 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081918 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081919 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081919 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081920 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081920 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081921 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081921 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081922 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081922 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081923 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081923 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081924 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081924 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081925 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081925 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081926 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081926 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081926 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081927 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081927 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081927 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081928 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081928 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081929 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081929 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081930 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081930 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081931 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081931 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081932 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081932 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081933 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081933 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081934 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081934 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081935 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081935 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081936 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081936 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081937 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081937 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1008 10081937 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081938 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081938 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081940 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081940 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081941 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081941 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081942 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081942 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081943 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1008 10081943 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091204 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091204 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091205 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091205 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091208 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091208 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091209 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091209 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091212 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091212 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091213 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091213 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091216 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091216 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091218 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091218 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091220 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091220 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091221 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091221 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091223 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091223 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091226 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091226 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091227 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091227 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091231 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091231 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091234 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091234 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091237 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091237 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091282 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091305 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091305 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091341 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091341 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091342 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091342 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091345 RACE1 Race1 NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERCRF C4591001DMC4591001 1009 10091345 RACE2 Race2 WHITE CRF C4591001DMC4591001 1009 10091345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091346 RACE1 Race1 NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERCRF C4591001DMC4591001 1009 10091346 RACE2 Race2 WHITE CRF C4591001DMC4591001 1009 10091346 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091347 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091347 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091348 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091348 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091349 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091349 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091350 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091350 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091355 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091355 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091357 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091357 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091359 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091359 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091360 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091360 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091365 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091374 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091378 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091378 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091380 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091380 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091381 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091381 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091382 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091382 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091385 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091385 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091386 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091386 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091387 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091387 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091388 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091388 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091389 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091389 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091390 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091390 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091391 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091391 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091392 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091392 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091393 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091393 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091396 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091396 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091398 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091398 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091399 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091399 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091400 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091400 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091401 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091401 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091402 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091402 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091403 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091403 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091404 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091404 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091405 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091405 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091406 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091406 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091407 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091407 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1009 10091407 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091408 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091408 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091409 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091409 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091410 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091410 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091411 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091411 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091412 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091412 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091413 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091413 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1009 10091414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131821 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131821 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131822 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131822 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131823 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131823 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131824 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131824 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131826 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131826 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131828 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131828 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131830 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131830 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131835 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131835 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131836 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131836 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131839 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131839 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131841 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131841 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131842 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131842 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131843 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131843 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131844 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131844 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131845 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131845 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131846 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131846 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131848 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131848 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131850 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131850 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131851 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131851 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1013 10131851 RACE2 Race2 WHITE CRF C4591001DMC4591001 1013 10131851 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131852 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131852 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131855 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131855 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131856 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131856 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131858 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131858 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131859 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131859 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131860 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131860 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131861 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131861 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131862 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131862 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131863 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131863 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131865 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131865 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131866 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131866 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131867 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131867 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131868 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131868 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1013 10131868 RACE2 Race2 WHITE CRF C4591001DMC4591001 1013 10131868 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131868 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131869 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131869 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131870 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131870 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131871 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131871 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1013 10131871 RACE2 Race2 WHITE CRF C4591001DMC4591001 1013 10131871 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131872 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131872 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1013 10131872 RACE2 Race2 WHITE CRF C4591001DMC4591001 1013 10131872 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131873 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131873 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131873 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131874 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131874 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131874 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131875 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131875 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1013 10131875 RACE2 Race2 WHITE CRF C4591001DMC4591001 1013 10131875 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131875 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131876 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131876 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131876 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131877 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131877 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131878 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131878 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131879 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131879 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131880 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131880 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131881 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131881 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131882 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131882 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131883 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131883 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131884 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131884 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1013 10131884 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131885 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131885 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131886 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1013 10131886 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161350 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161350 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161352 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161352 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161357 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161357 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161365 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161365 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1016 10161365 RACE2 Race2 WHITE CRF C4591001DMC4591001 1016 10161365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161367 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161367 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161368 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161368 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161370 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1016 10161370 RACE2 Race2 WHITE CRF C4591001DMC4591001 1016 10161370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161374 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161378 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161378 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161381 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161381 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161382 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161382 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1016 10161382 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161383 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1016 10161383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161385 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161385 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161386 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161386 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161387 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161387 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161388 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1016 10161388 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391260 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391268 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391276 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391294 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391305 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391305 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391309 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391314 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391317 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391325 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391326 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1039 10391326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1039 10391339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441260 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441290 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441322 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441336 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441339 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441341 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441341 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441342 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441342 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441343 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441344 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441346 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441347 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441347 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441348 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441348 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441349 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441349 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441350 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441350 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441350 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441352 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441352 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441355 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441355 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441355 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441357 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441357 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441358 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1044 10441358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441359 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441359 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441360 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441360 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441365 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441367 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441367 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441368 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441368 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441374 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441378 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441378 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441380 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441380 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441381 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441381 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441382 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441382 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1044 10441384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571378 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571378 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571379 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1057 10571379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571380 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571380 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571382 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571382 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571385 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571385 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571386 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571386 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571387 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571387 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571388 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571388 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571389 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571389 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571390 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571390 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571391 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571391 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571392 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571392 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571393 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571393 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571396 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571396 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571397 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571397 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571398 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571398 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571399 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571399 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571400 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571400 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571401 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571401 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571402 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571402 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571403 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571403 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571404 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571404 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571405 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571405 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571406 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571406 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571407 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571407 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571408 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571408 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571409 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571409 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571410 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571410 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1057 10571410 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571411 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571411 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571412 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571412 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571413 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571414 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1057 10571414 RACE2 Race2 WHITE CRF C4591001DMC4591001 1057 10571414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571415 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571415 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571416 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571416 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571417 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571417 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571418 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571418 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571419 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571419 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571420 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571420 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571421 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571421 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571422 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571422 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571423 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571423 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571424 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571424 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571425 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571425 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571426 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571426 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571427 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571427 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571429 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571429 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571430 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571430 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571431 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571431 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571432 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571432 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571433 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571433 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571434 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571434 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1057 10571434 RACE2 Race2 WHITE CRF C4591001DMC4591001 1057 10571434 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571435 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571435 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571436 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571436 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571437 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571437 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571438 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571438 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571439 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571439 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571440 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571440 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571441 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571441 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1057 10571441 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571442 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571442 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571443 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571443 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571444 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571444 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571445 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571445 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571446 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571446 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571447 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571447 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571448 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571448 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571449 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571449 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571450 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571450 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571451 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571451 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571452 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571452 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571453 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571453 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571454 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1057 10571454 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661397 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661397 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661401 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661401 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661402 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661402 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661403 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661403 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661404 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661404 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661405 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661405 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661407 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661407 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661408 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661408 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661409 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661409 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661410 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661410 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661411 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661411 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661412 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661412 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661415 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661415 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661416 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661416 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661417 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661417 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661418 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661418 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661419 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661419 RACE1 Race1 AMERICAN INDIAN OR ALASKA NATIVE CRF C4591001DMC4591001 1066 10661419 RACE2 Race2 WHITE CRF C4591001DMC4591001 1066 10661419 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661420 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661420 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661421 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661421 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661422 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661422 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661423 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661423 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661424 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661424 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661425 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661425 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661426 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661426 RACE1 Race1 NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERCRF C4591001DMC4591001 1066 10661426 RACE2 Race2 WHITE CRF C4591001DMC4591001 1066 10661426 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661427 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661427 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661429 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661429 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661430 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661430 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661431 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661431 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661432 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661432 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661433 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661433 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661434 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661434 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661435 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1066 10661435 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1077 10771300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841541 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841541 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841542 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841542 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841543 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841543 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841544 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841544 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841545 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841545 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841546 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841546 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841547 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841547 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841548 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841548 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841549 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841549 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841550 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841550 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841551 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841551 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841552 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841552 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841553 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841553 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841555 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841555 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841556 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841556 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841557 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841557 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841558 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841558 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841559 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841559 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841560 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841560 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841561 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841561 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841562 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841562 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841563 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841563 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841564 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841564 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841565 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841565 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841566 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841566 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841566 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841567 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841567 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841567 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841568 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841568 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841569 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841569 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841570 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841570 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841571 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841571 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841571 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841572 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841572 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841573 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841573 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841574 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841574 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841575 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841575 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841575 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841576 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841576 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841577 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841577 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841578 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841578 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841579 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841579 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841580 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841580 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841581 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841581 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841582 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841582 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841582 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841583 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841583 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841584 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841584 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841586 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841586 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841587 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841587 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841588 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841588 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841589 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841589 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841590 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841590 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841591 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841591 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841592 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841592 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1084 10841592 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841593 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841593 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841594 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841594 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841595 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841595 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841596 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841596 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841597 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1084 10841597 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911396 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911396 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911399 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911399 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911400 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911400 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911402 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911402 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911403 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911403 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911404 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911404 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911405 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911405 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911406 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911406 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911407 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911407 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911408 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911408 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911409 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911409 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911410 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911410 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911411 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911411 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911412 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911412 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1091 10911412 RACE2 Race2 WHITE CRF C4591001DMC4591001 1091 10911412 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911413 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911413 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911414 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911414 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911415 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911415 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911415 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911416 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911416 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911417 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911417 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911418 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911418 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911419 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911419 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911420 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911420 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911421 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911421 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911422 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911422 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911423 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911423 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911424 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911424 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911425 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911425 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911426 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911426 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911427 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911427 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911429 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911429 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911430 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911430 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911431 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911431 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911432 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911432 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911433 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911433 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911434 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911434 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911435 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911435 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911436 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911436 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911437 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911437 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911438 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911438 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911438 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911439 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911439 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911440 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911440 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911441 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911441 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911442 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911442 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911443 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911443 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911443 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911444 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911444 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911445 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911445 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911445 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911446 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911446 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911447 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911447 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911448 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911448 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911449 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911449 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911450 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911450 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1091 10911450 RACE2 Race2 WHITE CRF C4591001DMC4591001 1091 10911450 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911450 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911451 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911452 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911452 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911453 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911453 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911453 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911454 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911454 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1091 10911454 RACE2 Race2 WHITE CRF C4591001DMC4591001 1091 10911454 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911454 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911455 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911455 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911456 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911456 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911457 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911457 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911458 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911458 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911459 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911459 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911460 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911460 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911461 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911461 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1091 10911461 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911462 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911462 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911463 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911463 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911464 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911464 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911465 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911465 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911466 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1091 10911466 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231422 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231422 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231425 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231425 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231428 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231428 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231431 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231431 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231432 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231432 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231434 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231434 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231438 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231438 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231439 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231439 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231440 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231440 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231441 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231441 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231442 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231442 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231443 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231443 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231445 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231445 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231446 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231446 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231447 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231447 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231448 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231448 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231449 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231449 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231450 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231450 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231451 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231451 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231452 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231452 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231453 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231453 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231454 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231454 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231455 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231455 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231456 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231456 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231457 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231457 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231458 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231458 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231459 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231459 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231460 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231460 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231461 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231461 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231462 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231462 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231463 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231463 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231465 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231465 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231466 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231466 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231467 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231467 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231468 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231468 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231469 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231469 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231470 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231470 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231472 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231472 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231473 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231473 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231474 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231474 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231475 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231475 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231476 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231476 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231477 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231477 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231478 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231478 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231479 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231479 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231481 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231481 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231482 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231482 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231483 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231483 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1123 11231483 RACE2 Race2 WHITE CRF C4591001DMC4591001 1123 11231483 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231484 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231484 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231485 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231485 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231486 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231486 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231487 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231487 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231488 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231488 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231489 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231489 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231491 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231491 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231492 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231492 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231493 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231493 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231494 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231494 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231495 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231495 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231496 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231496 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231497 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231497 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231499 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231499 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231500 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231500 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231501 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231501 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231502 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231502 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231503 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231503 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231504 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231504 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231505 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231505 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231506 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231506 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231507 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231507 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231508 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231508 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231509 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231509 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231510 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231510 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231511 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231511 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231512 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231512 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231513 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231513 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231514 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231514 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231515 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231515 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231516 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231516 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231517 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231517 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231518 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231518 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231519 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231519 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231520 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231520 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231521 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231521 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231522 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231522 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231523 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231523 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231524 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231524 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231525 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231525 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231526 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1123 11231526 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241248 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241260 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1124 11241275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1125 11251255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261230 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261230 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261258 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1126 11261258 RACE2 Race2 WHITE CRF C4591001DMC4591001 1126 11261258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261300 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1126 11261300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261305 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261305 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261313 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1126 11261313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261315 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1126 11261315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261321 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1126 11261321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261322 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1126 11261322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261323 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1126 11261323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261324 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1126 11261324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1126 11261325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311279 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1131 11311279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1131 11311302 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1131 11311302 RACE2 Race2 WHITE CRF C4591001DMC4591001 1131 11311302 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1131 11311302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391144 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391144 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391145 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391145 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391151 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391151 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391152 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391152 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391154 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391154 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391155 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391155 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391156 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391156 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391157 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391157 RACE1 Race1 AMERICAN INDIAN OR ALASKA NATIVE CRF C4591001DMC4591001 1139 11391157 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391157 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391158 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391158 RACE1 Race1 AMERICAN INDIAN OR ALASKA NATIVE CRF C4591001DMC4591001 1139 11391158 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391158 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391159 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391159 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391161 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391161 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391162 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391162 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391163 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391163 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391165 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391165 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391166 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391166 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391168 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391168 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391169 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391169 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391169 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391170 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391170 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391170 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391171 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391171 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391172 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391172 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391173 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391173 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391174 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391174 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391175 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391175 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1139 11391175 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391175 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391177 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391177 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391178 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391178 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391179 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391179 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391180 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391180 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391181 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391181 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391182 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391182 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391183 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391183 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391185 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391185 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391186 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391186 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391187 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391187 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1139 11391187 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391187 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391187 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391188 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391188 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391189 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391189 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391190 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391190 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391191 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391191 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391192 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391192 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391193 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391193 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1139 11391193 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391193 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391195 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391195 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391196 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391196 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391197 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391197 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391198 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391198 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391199 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391199 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391200 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391200 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391200 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391201 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391201 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391202 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391202 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391203 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391203 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391204 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391204 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391205 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391205 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391206 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391206 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391207 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391207 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391208 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391208 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391209 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391209 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391210 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391210 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391211 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391211 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391212 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391212 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391213 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391213 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391214 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391214 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1139 11391214 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391214 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391215 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391215 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391216 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391216 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391217 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391217 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391218 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391218 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391219 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391219 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391220 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391220 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391221 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391221 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391222 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391222 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391223 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391223 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391224 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391224 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391225 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391225 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391226 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391226 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391227 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391227 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391228 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391228 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391229 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391230 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391230 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391231 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391231 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391232 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391232 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391236 RACE1 Race1 NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERCRF C4591001DMC4591001 1139 11391236 RACE2 Race2 WHITE CRF C4591001DMC4591001 1139 11391236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391237 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391237 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391241 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391258 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1139 11391258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391260 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1139 11391263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401344 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1140 11401344 RACE2 Race2 WHITE CRF C4591001DMC4591001 1140 11401344 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1140 11401344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401347 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401347 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401348 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401348 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401349 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401349 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401350 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401350 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401352 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401352 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401356 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1140 11401356 RACE2 Race2 WHITE CRF C4591001DMC4591001 1140 11401356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401357 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401357 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401359 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401359 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1140 11401359 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401365 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401367 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401367 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401374 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401378 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401378 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401380 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401380 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401381 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401381 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401382 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401382 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401385 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401385 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401386 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401386 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401387 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401387 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401388 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401388 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401389 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401389 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401390 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401390 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401391 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401391 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1140 11401391 RACE2 Race2 WHITE CRF C4591001DMC4591001 1140 11401391 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401392 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401392 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401393 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401393 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401396 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401396 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401397 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401397 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401398 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401398 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401399 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401399 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401400 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401400 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401401 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401401 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401402 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401402 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401403 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1140 11401403 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421341 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421341 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421342 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421342 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421343 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1142 11421343 RACE2 Race2 WHITE CRF C4591001DMC4591001 1142 11421343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421346 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421348 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421348 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421349 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421349 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421350 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421350 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421352 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421352 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421355 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421355 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1142 11421355 RACE2 Race2 WHITE CRF C4591001DMC4591001 1142 11421355 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421359 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421359 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1142 11421359 RACE2 Race2 WHITE CRF C4591001DMC4591001 1142 11421359 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421360 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421360 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421365 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421367 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421367 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421368 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421368 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421374 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421376 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421376 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421377 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421377 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421379 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421379 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421380 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421380 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1142 11421380 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421383 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421383 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421384 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421384 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421385 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421385 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421386 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421386 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421388 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421388 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421389 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421389 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421390 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421390 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421391 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421391 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421392 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421392 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421393 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421393 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421394 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421394 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421395 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421395 RACE1 Race1 AMERICAN INDIAN OR ALASKA NATIVE CRF C4591001DMC4591001 1142 11421395 RACE2 Race2 WHITE CRF C4591001DMC4591001 1142 11421395 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421396 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1142 11421396 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471292 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1147 11471292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471305 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471305 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471315 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471315 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471326 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471326 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471329 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471329 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1147 11471329 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471341 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471341 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1147 11471341 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471342 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471342 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1147 11471342 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471346 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471347 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1147 11471347 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1147 11471347 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501118 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501118 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501119 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501119 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501119 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501119 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501120 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501120 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501121 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501121 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501123 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501123 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501124 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501124 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501125 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501125 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501126 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501126 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501126 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501126 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501127 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501127 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501128 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501128 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501129 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501129 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501130 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501130 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501131 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501131 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501132 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501132 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501133 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501133 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501134 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501134 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501135 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501135 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501136 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501136 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501166 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501166 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501168 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501168 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501171 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501171 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501176 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501176 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501178 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501178 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501179 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501179 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501180 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501180 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501182 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501182 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501183 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501183 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501185 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501185 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501186 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501186 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501187 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501187 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501189 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501189 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501190 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501190 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501191 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501191 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501192 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501192 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501193 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501193 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501194 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501194 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501195 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501195 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501196 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501196 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501197 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501197 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501198 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501198 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501199 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501199 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501200 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501200 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501201 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501201 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501202 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501202 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501203 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501203 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501204 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501204 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501205 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501205 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501206 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501206 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501207 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501207 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501208 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501208 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501209 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501209 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501210 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501210 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501211 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501211 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501212 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501212 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501213 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501213 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501214 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501214 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501215 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501215 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501216 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501216 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501217 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501217 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501218 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501218 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501219 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501219 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501220 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501220 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501221 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501221 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501222 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501222 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501223 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501223 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501224 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501224 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501225 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501225 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501226 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501226 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501227 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501227 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501228 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501228 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501230 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501230 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501231 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501231 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501231 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501232 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501232 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501234 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501234 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501237 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501237 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501239 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501239 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501239 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501255 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501255 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501255 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501256 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501256 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501256 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501258 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501258 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501260 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501261 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501261 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501263 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501264 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501264 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501264 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501266 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501266 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1150 11501266 RACE2 Race2 WHITE CRF C4591001DMC4591001 1150 11501266 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501266 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501282 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501282 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501287 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501287 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501288 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501288 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501289 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501289 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501290 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501290 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501291 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501291 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501292 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501292 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501293 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501293 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501294 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501294 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501295 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501295 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501296 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501296 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501297 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501297 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501298 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501298 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1150 11501298 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501299 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501299 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501300 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501300 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501301 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501301 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501302 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1150 11501302 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521604 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521604 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521605 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521605 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521607 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521607 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521608 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521608 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521611 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521611 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521612 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521612 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521613 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521613 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521614 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521614 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521615 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521615 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521617 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521617 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521619 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521619 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521625 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521625 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521626 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521626 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521628 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521628 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521629 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521629 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521633 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521633 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521635 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521635 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521636 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521636 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521637 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521637 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521638 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521638 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521639 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521639 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521640 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521640 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521641 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521641 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521642 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521642 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521644 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521644 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521645 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521645 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521646 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521646 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521647 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521647 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521648 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521648 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521649 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521649 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521650 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521650 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521651 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521651 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521652 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521652 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521653 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521653 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521654 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521654 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521655 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521655 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1152 11521655 RACE2 Race2 WHITE CRF C4591001DMC4591001 1152 11521655 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521656 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521656 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521657 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521657 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521658 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521658 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521659 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521659 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521660 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521660 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521661 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521661 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521662 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521662 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521662 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521663 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521663 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521663 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521664 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521664 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521665 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521665 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521666 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521666 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521667 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521667 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521668 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521668 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521669 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521669 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521669 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521670 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521670 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521671 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521671 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521672 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521672 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521673 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521673 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521674 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521674 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521675 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521675 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521676 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521676 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521677 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521677 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521678 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521678 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521679 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521679 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521680 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521680 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521681 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521681 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521682 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521682 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521683 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521683 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521684 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521684 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521685 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521685 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521686 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521686 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521687 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521687 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521688 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521688 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521689 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521689 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521690 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521690 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521691 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521691 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521692 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521692 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521693 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521693 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1152 11521693 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521694 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521694 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1152 11521694 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521695 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521695 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521696 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521696 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521697 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521697 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521697 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521698 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521698 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521699 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521699 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521700 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521700 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521700 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521701 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521701 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521702 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521702 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521703 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521703 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521704 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521704 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521705 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521705 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521706 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521706 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521707 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521707 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521708 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521708 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521709 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521709 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521710 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521710 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521711 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521711 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521712 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521712 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521713 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521713 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521714 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521714 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521715 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521715 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521716 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521716 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521717 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521717 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521718 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521718 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521718 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521719 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521719 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521720 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521720 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521721 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521721 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521722 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521722 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521723 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521723 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521724 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521724 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521725 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521725 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521726 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521726 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521726 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521727 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521727 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521728 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521728 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521728 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521729 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521729 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521730 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521730 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521731 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521731 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521732 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521732 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521733 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521733 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521734 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521734 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521735 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521735 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521736 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521736 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521737 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521737 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521738 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521738 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521739 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521739 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521740 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521740 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521741 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521741 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521742 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521742 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521742 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521743 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521743 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521744 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521744 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521745 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521745 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521745 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521746 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521746 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521746 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521747 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521747 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521748 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521748 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521749 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521749 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1152 11521749 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521750 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521750 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521751 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521751 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521752 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521752 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1152 11521752 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521753 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521753 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1152 11521753 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521754 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521754 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521755 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521755 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521756 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521756 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521757 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1152 11521757 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561255 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561255 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561256 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561256 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561257 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561257 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561259 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561259 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561260 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561260 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561262 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561262 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561263 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561263 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561264 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561264 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561265 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561265 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561303 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561303 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561304 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561304 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561305 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561305 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561306 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561306 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561307 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561307 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561308 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561308 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561309 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561309 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561310 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561310 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561311 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561311 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561312 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561312 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561313 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561313 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561314 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561314 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561316 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561316 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561317 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561317 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561318 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561318 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561319 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561319 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561320 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561320 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561321 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561321 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561322 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561322 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561323 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561323 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561324 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561324 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561325 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561325 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561327 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561327 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561328 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561328 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561330 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561330 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561331 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561331 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561332 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561332 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561333 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561333 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561334 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561334 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561335 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561335 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561336 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561336 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561337 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561337 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561338 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561338 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561339 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561339 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561340 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561340 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561341 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561341 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561342 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561342 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561343 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561343 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561344 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561344 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561345 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561345 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561346 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561346 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561347 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561347 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561348 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561348 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561349 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561349 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561351 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561351 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561352 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561352 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561353 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561353 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561354 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561354 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561355 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561355 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561356 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561356 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561357 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561357 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561358 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561358 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561359 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561359 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561360 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561360 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561361 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561361 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561362 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561362 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561363 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561363 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561364 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561364 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561365 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561365 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561366 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561366 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561367 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561367 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561368 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561368 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561369 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561369 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561370 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561370 RACIALD Racial Designation JAPANESE CRF C4591001DMC4591001 1156 11561370 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561371 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561371 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561372 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561372 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561373 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561373 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561374 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561374 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1156 11561374 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561375 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1156 11561375 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231267 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231267 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231268 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231268 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231269 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231269 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231270 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231270 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231271 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231271 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231272 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231272 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231273 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231273 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231274 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231274 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231275 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231275 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231276 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231276 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1223 12231276 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231277 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231277 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231278 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231278 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231279 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231279 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231280 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231280 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231281 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231281 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231283 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231283 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231284 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231284 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231285 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231285 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231286 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1223 12231286 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351232 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351232 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351234 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351234 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351243 CDECASE Clinical disease endpoint case flagY DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351245 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351245 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351246 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351246 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1235 12351246 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351247 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351247 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1235 12351247 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351248 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351248 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351249 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351249 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351250 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351250 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351251 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351251 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351252 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351252 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351253 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351253 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351254 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1235 12351254 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701173 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701173 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701174 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701174 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701177 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701177 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701180 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701180 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701181 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701181 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701184 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701184 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701187 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701187 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701188 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701188 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701189 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701189 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701191 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701191 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701192 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701192 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1270 12701192 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701192 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701194 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701194 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701198 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701198 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701199 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701199 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701200 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701200 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701201 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701201 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701202 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701202 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701203 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701203 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701204 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701204 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701205 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701205 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1270 12701205 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701205 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701206 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701206 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701207 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701207 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701208 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701208 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701209 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701209 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701210 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701210 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701211 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701211 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701212 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701212 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701213 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701213 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701214 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701214 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701215 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701215 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701216 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701216 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1270 12701216 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701216 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701217 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701217 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701218 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701218 RACE1 Race1 ASIAN CRF C4591001DMC4591001 1270 12701218 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701218 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701219 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701219 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701220 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701220 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701221 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701221 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701222 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701222 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701223 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701223 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701224 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701224 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701225 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701225 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1270 12701225 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701226 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701226 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1270 12701226 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701227 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701227 RACIALD Racial Designation OTHER CRF C4591001DMC4591001 1270 12701227 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701228 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701228 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701229 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701229 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701230 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701230 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1270 12701230 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701230 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701231 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701231 RACE1 Race1 BLACK OR AFRICAN AMERICAN CRF C4591001DMC4591001 1270 12701231 RACE2 Race2 WHITE CRF C4591001DMC4591001 1270 12701231 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701232 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701232 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701233 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701233 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701234 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701234 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701235 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701235 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701236 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701236 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701237 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701237 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701238 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701238 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701239 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701239 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701240 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701240 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701241 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701241 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701242 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701242 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701243 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701243 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701244 CDECASE Clinical disease endpoint case flagN DERIVEDCLINICAL STUDY SPONSORC4591001DMC4591001 1270 12701244 REACTOFLReactogenicity Population Flag Y DERIVEDCLINICAL STUDY SPONSOR